276 related articles for article (PubMed ID: 29317115)
21. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
22. N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement.
Yu J; Wang W
J Cardiothorac Surg; 2023 Oct; 18(1):286. PubMed ID: 37817246
[TBL] [Abstract][Full Text] [Related]
23. The Determinants and Outcomes of Myocardial Injury After Transcatheter Aortic-Valve Implantation: SAPIEN 3 Study.
Sato T; Aizawa Y; Yuasa S; Taya Y; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
Cardiovasc Revasc Med; 2020 Aug; 21(8):973-979. PubMed ID: 31924486
[TBL] [Abstract][Full Text] [Related]
24. Periprocedural changes in natriuretic peptide levels and clinical outcome after transcatheter mitral valve repair.
Tanaka T; Kavsur R; Spieker M; Iliadis C; Metze C; Horn P; Sugiura A; Kelm M; Baldus S; Nickenig G; Westenfeld R; Pfister R; Becher MU
ESC Heart Fail; 2021 Dec; 8(6):5237-5247. PubMed ID: 34519444
[TBL] [Abstract][Full Text] [Related]
25. Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation.
Stundl A; Lünstedt NS; Courtz F; Freitag-Wolf S; Frey N; Holdenrieder S; Zur B; Grube E; Nickenig G; Werner N; Frank D; Sinning JM
Am J Cardiol; 2017 Sep; 120(6):986-993. PubMed ID: 28739033
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
[TBL] [Abstract][Full Text] [Related]
27. Presepsin predicts 1-year all-cause mortality better than N-terminal pro-B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
Weferling M; Fischer-Rasokat U; Vietheer J; Renker M; Rolf A; Keller T; Choi YH; Arsalan M; Hamm CW; Kim WK; Liebetrau C
Biomark Med; 2022 Dec; 16(17):1209-1218. PubMed ID: 36861450
[TBL] [Abstract][Full Text] [Related]
28. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Prognostic Value of High-Sensitivity Troponin T Added to N-Terminal Pro Brain Natriuretic Peptide Plasma Levels Before Valve Replacement for Severe Aortic Stenosis.
Barbieri F; Senoner T; Adukauskaite A; Dobner S; Holfeld J; Semsroth S; Lambert T; Zweiker D; Theurl T; Rainer PP; Schmidt A; Feuchtner GM; Steinwender C; Hoppe UC; Hintringer F; Bauer A; Müller S; Grimm M; Pfeifer BE; Dichtl W
Am J Cardiol; 2019 Dec; 124(12):1932-1939. PubMed ID: 31699359
[TBL] [Abstract][Full Text] [Related]
30. Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome.
Denegri A; Mehran R; Holy E; Taramasso M; Pasotti E; Pedrazzini G; Moccetti T; Maisano F; Nietlispach F; Obeid S
Catheter Cardiovasc Interv; 2019 Jan; 93(1):141-148. PubMed ID: 30269398
[TBL] [Abstract][Full Text] [Related]
31. Elevated growth differentiation factor 15 levels predict outcome in patients undergoing transcatheter aortic valve implantation.
Krau NC; Lünstedt NS; Freitag-Wolf S; Brehm D; Petzina R; Lutter G; Bramlage P; Dempfle A; Frey N; Frank D
Eur J Heart Fail; 2015 Sep; 17(9):945-55. PubMed ID: 26230285
[TBL] [Abstract][Full Text] [Related]
32. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
33. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
34. The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation.
Spargias K; Polymeros S; Dimopoulos A; Manginas A; Pavlides G; Balanika M; Smirli A; Stavridis G; Dangas G; Cokkinos DV
J Interv Cardiol; 2011 Oct; 24(5):462-9. PubMed ID: 21883470
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
36. N-Terminal Pro-B-Type Natriuretic Peptide in Tricuspid Valve Replacement.
Cheng Y; Ou J; Tang B; Wang Q; Liang M; Wang Z; Wu Z
Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):801-810. PubMed ID: 32473963
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of plasma N-terminal pro B-type natriuretic peptide levels in pneumonia patients requiring intensive care unit admission.
Lin SC; Tsai YJ; Huang CT; Kuo YW; Ruan SY; Chuang YC; Yu CJ
Respirology; 2013 Aug; 18(6):933-41. PubMed ID: 23600467
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
39. Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery.
Liu H; Wang C; Liu L; Zhuang Y; Yang X; Zhang Y
J Cardiothorac Surg; 2013 Jan; 8():1. PubMed ID: 23289601
[TBL] [Abstract][Full Text] [Related]
40. Association of N-terminal pro-brain natriuretic peptide with contrast-induced acute kidney injury and long-term mortality in patients with heart failure and mid-range ejection fraction: An observation study.
Wang K; Li HL; Chen LL; Bei WJ; Lin KY; Smyth B; Chen SQ; Guo XS; Guo W; Liu YH; Chen PY; Chen JY; Chen KH; Liu Y; Tan N
Medicine (Baltimore); 2017 Mar; 96(10):e6259. PubMed ID: 28272231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
